Pharmaceutical Pricing

How New Platforms Are Saving Patients $4 Billion on Prescription Drugs

September 6, 2023 - Today, Visory Health announced that it is ranked the fourth-largest prescription discount card in the United States, based on an analysis from IQVIA. The company revealed that it has saved 3.25 million patients approximately $4.13 billion in drug costs through drug cards and partnerships with pharmacies. Across the US, drug costs have been...

Read More


More Articles

Ozempic in the US Costs Over Five Times More Than in Other Countries

by Veronica Salib

As weight loss drugs like Ozempic, Wegovy, and Mounjaro become increasingly popular in the United States, the financial weight of these drugs poses a significant burden for the US healthcare system....

California Partners with Civica to Make Affordable Insulin Available

by Veronica Salib

One day into his second term, Governor Gavin Newsom of California has announced a partnership between CalRx, a California Department of Healthcare Services program, and Civica, a healthcare nonprofit,...

Anticipating the 2023 Biosimilar Boom

by Veronica Salib

A recent analysis by Vantage Market Research found that in 2021 the global biosimilars market was valued at $28.46 billion. Projections based on market trajectory predict that the market will surpass $103.94 billion by 2028. While...

Kroger Health to End Express Scripts Pharmacy Provider Agreement

by Hayden Schmidt

Last week, Kroger Health — the grocery store chain’s pharmacy business — surprised Express Scripts with written notice of intention to terminate their agreement for commercial...

Drug Costs Are Not Justified by Research and Development Costs

by Veronica Salib

It’s no secret that drug costs in the United States have continued to increase in the past few years. The Kaiser Family Foundation states that between 2019 and 2022, 48% of prescription drugs had...

Antitrust Lawsuit against Generic Pharmaceutical Companies Is Amended

by Hayden Schmidt

A Pennsylvania Judge barred plaintiffs in an antitrust lawsuit from recouping substantial financial penalties in their case against a group of pharmaceutical companies. Judge Cynthia Rufe will not...

Price for COVID-19 Treatment May Range from $10 to $4K, ICER Says

by Samantha McGrail

Using two different alternative pricing models, the Institute for Clinical and Economic Review (ICER) determined that the price for remdesivir could range from $10 to over $4,000. For more coronavirus...

GoodRx Names Top 20 Most Expensive Prescription Drugs in 2020

by Samantha McGrail

According to a GoodRx analysis, Myalept is the most expensive prescription drug in the US in 2020 with a list price of $72,306.  In their yearly analysis, GoodRx researchers broke down the most...

CMS Moves to Foster Access to Generics, Biosimilars in New Rule

by Ana Mulero

The Trump administration put out a proposed rule on Wednesday that aims to foster access to generics and biosimilars through a push for price transparency around pharmaceutical drugs administered under...

FTC, NY Sue to Ban Martin Shkreli From Pharmaceutical Industry

by Ana Mulero

The Federal Trade Commission and the New York Attorney General Letitia James filed a complaint in federal court against Vyera Pharmaceuticals, Martin Shkreli and Kevin Mulleady, seeking to ban the...

CA Proposes Single Market for Drug Pricing, Manufacturing Hub

by Ana Mulero

The state of California is set to propose, as early as this spring, two initiatives to establish a single market for drug pricing within the state and a new contracting program for generic...

Role of Pharmacy Benefit Managers in the Pharmaceutical Supply Chain

by Sara Heath

As the healthcare industry works to tackle skyrocketing spending, a keen eye is turning toward the pharmaceutical industry. And with that, experts are examining the role pharmacy benefits managers play...

Exploring International Reference Pricing for Pharmaceuticals

by Jacqueline LaPointe

In October 2018, the Trump administration proposed an international reference pricing model to reduce the federal government's spending on prescription drugs. The International Pricing Index (IPI)...

Recent Articles